Structural LV remodelling, a common event in the progression of heart failure, causes progressive dilatation of the left ventricle and pump dysfunction.
Our study showed that HDAC inhibition attenuates progressive dysfunction, suggesting that HDACs play an important role in controlling the progression of heart failure.
Most patients stopped or reversed the progression of heart disease.
Coronary endothelial dysfunction may potentially lead to myocardial ischemia and to the progression of heart failure.
The potential of these procedures to slow the progression of heart failure needs to be confirmed in prospective studies.
Just two weeks ago, researchers reported that estrogen did nothing to slow the progression of heart disease in women whose arteries had already been partly blocked by it.
Yamamoto, R. et al. Angiotensin II type 1a receptor signals are involved in the progression of heart failure in MLP-deficient mice.
Morita, H. et al. Long-term effects of non-excitatory cardiac contractility modulation electric signals on the progression of heart failure in dogs.
The following review outlines recent advances in medical and surgical approaches to control the remodeling process that underlies the progression of heart failure.
Recently studies indicated that valsartan could prevent the progression of heart failure caused by diabetic cardiomyopathy (DCM), while the mechanisms were still poorly understood.
The present study investigated whether the HGF sheet could prevent the progression of heart failure in stroke-prone spontaneously hypertensive rats.
